Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 42 cancer biomarkers PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
cancer biomarkers PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 42 cancer biomarkers PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Using single cell transcriptomic and blood proteomic data to understand how pancreatic cancer causes diabetes and to find ways to detect the cancer earlier.
Background. Pancreatic cancer is the deadliest of the common cancers. Five-year survival remains low at 10%. Sadly for 80% of patients, by the time their cancer is diagnosed it has spread to distant organs making them ineligible for potentially curative surgery. Read more
Evaluation of RNA Epigenetic modifications as non-invasive biomarkers for human diseases
The proposed project is within the broad area of biomedical genomics for healthy ageing. Globally, the major focus is to identify biomarkers for human diseases, that can help early diagnosis and prognosis of the disease towards a better management and a better quality of life for an ageing population. Read more
Last chance to apply
Towards early cancer diagnosis: cancer biomarker screening using unique Raman spectroscopic solutions
Applications are invited for a fully-funded three year PhD to commence in October 2023. The PhD will be based in the Faculty of Science & Health, and will be supervised by. Read more
Developing Bioorthogonal Catalysts for Cancer Biomarker Detection
This is an exciting PhD studentship to develop new chemical tools for cancer research. We will develop a new class of bioorthogonal chemistry to interrogate cancer biomarkers, underpinning novel diagnostic technologies for early detection. . Read more
Investigating the efficacy of urine, tissue and blood-based biomarkers for the detection of non-muscle invasive bladder cancer (recurrence/progression)
The . Maelor Academic Unit of Medical & Surgical Sciences (MAUMSS). Read more
Use of Oxford Nanopore Technology liquid biopsy workflows for early cancer detection, tissue-of-origin prediction and personalising cancer treatment.
Project highlights. Explore the use of third-generation sequencing technology to detect cancer early using liquid biopsies. Read more
Last chance to apply
PhD studentship - Patient-derived cancer models to identify novel biomarkers and treatment targets in patients with prostate cancer
Overview. Prostate cancer (PCa) is the most common cancer among men in the UK with >50,000 new cases and >12,000 cancer-associated deaths annually. Read more
Biological significance, predictive value and targeting of cell surface antigens in colorectal cancer.
Despite major advances in its early detection, preventive measures and therapeutic options, colorectal cancer is the fourth most commonly diagnosed cancer and the third leading cause of cancer deaths worldwide. Read more
ctDNA meets Patient Derived Explants (PDEs): developing ctDNA predictive biomarkers for novel anti-cancer agents derived from PDE meta-data
Project highlights. This project sits at the interface of translational and clinical science. Will utilise state-of-the-art preclinical models coupled to high-content data analytics. Read more
Cancer: Epigenetic therapy using microbubble-mediated drug delivery for colorectal cancer
The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (including DNA methyltransferase inhibitors, HDAC inhibitors and/or vitamin C), as a potential combination therapy for colorectal cancer (CRC). Read more
Cancer: Complex 3D modelling of the tumour microenvironment for immunotherapy combination screening
Cancer immunotherapy holds significant promise for the treatment of a range of cancers. Read more
COLO-PREVENT ex vivo: the application of patient derived tissue models for investigating mechanisms of action of aspirin, metformin and resveratrol in the prevention of colorectal cancer.
Project Highlights. Work alongside a world first cancer prevention trial platform to help us understand mechanisms of action for aspirin, metformin and the dietary derived compound resveratrol. Read more
Personalising cancer treatment with modelling tumour evolution based on genomics biomarkers and PK/PD
Tumour heterogeneity is a major problem limiting the efficacy of targeted oncological therapies. Most advanced tumours eventually become resistant to the treatments, ultimately making the patient succumb to metastatic disease. Read more
Identification of biomarkers of drug response in soft tissue uterine sarcoma
We are excited to advertise this Edinburgh Doctoral College Scholarship for the Institute of Genetics and Cancer. . Further details of the scheme and application process can be found at. Read more
Investigating the clinical and molecular significance of the microbiome in breast cancer
Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more